To evaluate whether the interaction of CXCL12 and CXCR4 is significant in the mechanism of FAP+ stromal‐mediated immunosuppression, tumor‐bearing mice were treated with AMD3100, resulting in a T‐cell mediated reduction in tumor growth. The gene discussed is CXCR4; the disease is neoplasm.